This inventor holds 2 USPTO granted patents. Top assignee: Taipei Medical University. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2023
Title: Innovations by Chia-Feng Lu
Introduction
Chia-Feng Lu is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical technology, particularly in methods for assessing ischemic conditions in the brain. With a total of 2 patents, his work is recognized for its potential impact on stroke diagnosis and treatment.
Latest Patents
Chia-Feng Lu's latest patents focus on innovative methods for determining ischemic status and assessing stroke onset time in brain regions. The first patent describes a method that involves acquiring magnetic resonance diffusion tensor matrices to evaluate the relative decrease of diffusion magnitude due to ischemic status. This method aims to enhance the accuracy of ischemic status determination. The second patent similarly addresses stroke assessment, utilizing magnetic resonance diffusion tensor matrices to obtain a relative decrease of pure anisotropy due to stroke. These inventions represent a significant advancement in the medical field, providing tools for better diagnosis and timely intervention.
Career Highlights
Chia-Feng Lu is affiliated with Taipei Medical University, where he contributes to research and development in medical technologies. His work is characterized by a commitment to improving patient outcomes through innovative solutions.
Collaborations
Chia-Feng Lu collaborates with esteemed colleagues, including Cheng-Yu Chen and Hsiao-Wen Chung. Their combined expertise fosters a productive research environment that enhances the development of groundbreaking medical technologies.
Conclusion
Chia-Feng Lu's contributions to medical technology through his patents demonstrate his dedication to advancing healthcare solutions. His innovative methods for assessing ischemic conditions have the potential to significantly improve stroke diagnosis and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
